Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Candesartan versus amlodipine for microcirculation in essential hypertension
ISRCTN62554526Phase 4Completed
- Sponsor
- St George's, University of London
- Start
- Feb 2010
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
01
Overview
Phase 4, randomised, single-blind trial in essential hypertension comparing Candesartan with Amlodipine (2 arms). Primary endpoint: Increase in maximal capillary density. Started Feb 2010; status: completed.
02
Drugs
candesartanamlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on ISRCTN62554526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN62554526.